Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BYSANTI safely and effectively. See full prescribing information for BYSANTI. BYSANTI™ (milsaperidone) tablets, for oral use Initial U.S. Approval: 2026
Medication labelWhy this: Advisory · dailymed-prescription
BYSANTI™ is indicated for the: Treatment of schizophrenia in adults [see Clinical Studies (14.1)]. Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults [see Clinical Studies (14.2)].
- generic_name
- milsaperidone
- product_names
- MILSAPERIDONE
- ndc
- 43068-701, 43068-701-02, 43068-908, 43068-908-14, 43068-702, 43068-702-02, 43068-704, 43068-704-02, 43068-706, 43068-706-02, 43068-910, 43068-910-14, 43068-708, 43068-708-02, 43068-911, 43068-911-14, 43068-710, 43068-710-02, 43068-712, 43068-712-02, 43068-713, 43068-713-04, 43068-714, 43068-714-04, 43068-715, 43068-715-03, 43068-912, 43068-912-08, 43068-913, 43068-913-12, 43068-914, 43068-914-08
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en